Clinical Research Webinars

Transplant-Associated Thrombotic Microangiopathy (TA-TMA): Consensus Definitions & Up-to-Date Management

Watch the on-demand webinar where we’ll explore the significance of TTV in clinical settings and its potential as an objective aid for modifying immunosuppression in transplant recipients. Discover the latest diagnostic tools and methodologies that utilize TTV, along with real-world examples showcasing its impact on patient outcomes. The session will also include an interactive Q&A. Don’t miss this opportunity to enhance your understanding of TTV in transplant care!

Join us for an insightful webinar featuring Dr. Stella Davies, a distinguished pediatric hematologist-oncologist from Cincinnati Children's. In this presentation, Dr. Davies will delve into the complexities of Thrombotic Microangiopathy (TA-TMA), exploring its underlying causes and implications. With over 20 years of experience, Dr. Davies offers a comprehensive look at the latest research and clinical perspectives on this critical condition. Don't miss this opportunity to gain valuable knowledge from a leading expert in the field.

Join us for an insightful presentation by Dr. Luis Ostrosky-Zeichner, MD, where we explore the latest advancements and emerging trends in the field of medical mycology. The discussion covers critical topics such as current epidemiological data, evolving nomenclature standards, and recent innovations in antifungal treatments. Additionally, the video delves into the necessity for new diagnostic methods to keep pace with novel drugs and examines the evolving practices in clinical trial conduct. Join us for a comprehensive update on where medical mycology stands today and what the future holds.

Join us for an insightful discussion with Steve Kleiboeker, PhD Vice President, R & D, HCLD/TS/CC (ABB) Chief Scientific Officer, and James Grantham, Senior Scientist, Eurofins Viracor. View the webinar on TTV Viral Load for Monitoring the Net State of Immune Suppression. Don't miss this opportunity to delve into cutting-edge insights.

Join us for an insightful on-demand webinar featuring Abigail Servais, PharmD, BCTXP, and Steve Kleiboeker, PhD, as they delve into a groundbreaking protocol at an academic medical center. This protocol incorporates serial assessment of CMV T Cell Immunity Panel (CMV-TCIP) to tailor valganciclovir prophylaxis duration for high-risk kidney transplant patients. Discover their findings on the risk of CMV disease following early discontinuation of prophylaxis and the predictors identified through CMV T cell immunity assessment. Gain valuable insights into optimizing CMV management strategies based on immunological markers.

Join us for an insightful discussion with Dr. Anthony Sabulski, a renowned expert in TA-TMA among HSCT patients. Dr. Sabulski's vital research has focused on identifying at-risk patients and implementing early interventions to enhance transplant outcomes. In this webinar, explore the latest treatment strategies aimed at improving post-transplant patient lives, including a comprehensive review of past and present approaches to TA-TMA, the efficacy of C5 inhibition, and emerging therapies shaping future directions in TA-TMA management. Don't miss this opportunity to delve into cutting-edge insights and optimize treatment outcomes.

The Practical Use of CMV inSIGHT™ (CMV T Cell Immunity testing) in the Lung Transplant Recipient

Discovering & Developing Next Generation Diagnostic Tools for the Early Detection of TA-TMA

Dr. Anthony Sabulski, a leading physician and researcher of TA-TMA in HSCT patients, has been involved in essential research to identify patients at risk for this complication and to implement early interventions to improve TA-TMA associated transplant outcomes. View this interactive webinar highlighting the latest research and case studies of the clinical usage of this diagnostic tool aimed at improving the lives of post-transplant patients. Followed by a Q&A Session.

The National CMV Foundation, Leading Physicians cCMV Testing Advocates, and Eurofins Viracor will help you learn more about congenital cytomegalovirus (cCMV) and how early testing with non-invasive sample types (like saliva) can lead to improved outcomes. This succinct and informative webinar will discuss the impact testing can make for neonates at risk, types of testing, and the advocacy work you can get involved with (not only in June, but year round). The great panel also answers viewer's questions after the main presentation.